Redhill Biopharma
RDHL
#11160
Rank
NZ$4.56 M
Marketcap
NZ$0.51
Share price
-13.08%
Change (1 day)
-72.38%
Change (1 year)

Redhill Biopharma (RDHL) - Total assets

Total assets on the balance sheet as of June 2026 : NZ$48.02 Million

According to Redhill Biopharma's latest financial reports the company's total assets are NZ$48.02 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Redhill Biopharma - Total assets on balance sheet (from 2011 to 2026)

Total assets by year

Year Total assets Change
2025-12-31NZ$43.76 M36.79%
2024-12-31NZ$31.99 M-12.21%
2023-12-31NZ$36.44 M-85.44%
2022-12-31NZ$0.25 B-5.67%
2021-12-31NZ$0.26 B6.19%
2020-12-31NZ$0.24 B127.04%
2019-12-31NZ$0.11 B18.25%
2018-12-31NZ$93.04 M15.24%
2017-12-31NZ$80.74 M-24.64%
2016-12-31NZ$0.10 B9.72%
2015-12-31NZ$97.64 M165.12%
2014-12-31NZ$36.82 M111.05%
2013-12-31NZ$17.45 M-28.57%
2012-12-31NZ$24.42 M-5.55%
2011-12-31NZ$25.86 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Sanofi
SNY
NZ$269.26 B 560,530.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$237.27 B 493,932.12%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$173.85 B 361,870.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$72.85 B 151,597.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
NZ$3.95 B 8,133.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel